Dong Lyu
Director/Board Member chez GENOR BIOPHARMA HOLDINGS LIMITED
Profil
Dong Lyu is currently a Non-Executive Director at Luye Pharma Group Ltd., Genor Biopharma Holdings Ltd., and a Managing Director at Zhuhai Hillhouse Investment Management Holding Co. Ltd.
and Zhuhai Gao Ling Equity Investment Management Co. Ltd.
He previously held positions as a Director at Shanghai Ark Biopharmaceutical Co., Ltd., Non-Executive Director at Keymed Biosciences, Inc., Jacobio Pharmaceuticals Group Co., Ltd., and Clover Biopharmaceuticals Ltd.
He was also a Managing Director at Pag Growth Zhuhai Holding Investment Management Co. Ltd.
and VP- Pharmaceutical & Medical Device Investment at Shanghai Panxin Equity Investment Management Co. Ltd.
Dr. Lyu received his undergraduate degree from Beijing Medical University, his graduate degree from Peking University, and his doctorate from China Pharmaceutical University.
Postes actifs de Dong Lyu
| Sociétés | Poste | Début |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 02/11/2021 |
| LUYE PHARMA GROUP LTD. | Director/Board Member | 06/12/2023 |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 30/09/2020 |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01/09/2020 |
Anciens postes connus de Dong Lyu
| Sociétés | Poste | Fin |
|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 31/08/2023 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 28/10/2022 |
| KEYMED BIOSCIENCES INC. | Director/Board Member | 29/03/2022 |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | 01/09/2020 |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01/07/2016 |
Formation de Dong Lyu
| Peking University | Graduate Degree |
| China Pharmaceutical University | Doctorate Degree |
| Beijing Medical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| LUYE PHARMA GROUP LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| KEYMED BIOSCIENCES INC. | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Panxin Equity Investment Management Co. Ltd. | |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. |
